Celiac disease: a model autoimmune disease with gene therapy applications (Q35122155)

6 August 2017

1 reference

title

Celiac disease: a model autoimmune disease with gene therapy applications (English)

1 reference

6 August 2017

0 references

1 reference

Londei M

1 reference

6 August 2017

Quaratino S

series ordinal

1 reference

6 August 2017

Maiuri L

series ordinal

1 reference

6 August 2017

publication date

1 May 2003

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

1 reference

6 August 2017

page(s)

835-843

1 reference

Gene therapy: trials and tribulations

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Gene therapy - promises, problems and prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Gene therapy progress and prospects: cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

The Nobel Lectures in Immunology. The Nobel Prize for Physiology or Medicine, 1990. Bone marrow transplantation--past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Bone marrow transplantation in the treatment of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Bone marrow transplantation for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Pathogenic lymphoid cells engineered to express TGF β1 ameliorate disease in a collagen-induced arthritis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Antigen-specific T cell-mediated gene therapy in collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Dendritic cells genetically engineered to express IL-4 inhibit murine collagen-induced arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Gene therapy that inhibits nuclear translocation of nuclear factor kappaB results in tumor necrosis factor alpha-induced apoptosis of human synovial fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Molecular basis of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Reaction of human non-collagenous polypeptides with coeliac disease autoantibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Seroconversion of reticulin autoantibodies predicts coeliac disease in insulin dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Improved method for serological testing in celiac disease--IgA anti-endomysium antibody test: a comparison between monkey oesophagus and human umbilical cord as substrate in indirect immunofluorescence test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Identification of tissue transglutaminase as the autoantigen of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Autoantibodies to tissue transglutaminase as predictors of celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

T cell recognition of carbohydrates on type II collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Influence of a dominant cryptic epitope on autoimmune T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Structural basis for gluten intolerance in celiac sprue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

FAS engagement drives apoptosis of enterocytes of coeliac patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Interleukin 15 mediates epithelial changes in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Histological changes in small bowel mucosa induced by gliadin sensitive T lymphocytes can be blocked by anti-interferon gamma antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Interleukin 15: biology and relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Engineering mouse T lymphocytes specific to type II collagen by transduction with a chimeric receptor consisting of a single chain Fv and TCR zeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Alpha 4 beta 7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Interleukin 10 gene transfer prevents experimental colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Efficient gene delivery to the inflamed colon by local administration of recombinant adenoviruses with normal or modified fibre structure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Prevention of colitis by interleukin 10-transduced T lymphocytes in the SCID mice transfer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Serum immunoglobulin A from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Natural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

The Sushi domain of soluble IL-15 receptor alpha is essential for binding IL-15 and inhibiting inflammatory and allogenic responses in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

IL-15Ralpha recycles and presents IL-15 In trans to neighboring cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Selective expansion of intraepithelial lymphocytes expressing the HLA-E–specific natural killer receptor CD94 in celiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Bone marrow transplantation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Mortality in patients with coeliac disease and their relatives: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

Gene therapy of severe combined immunodeficiencies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Immunotherapy through TCR gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

1 reference

7 January 2021

Cancer risk in celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Definition of the initial immunologic modifications upon in vitro gliadin challenge in the small intestine of celiac patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Blockage of T-cell costimulation inhibits T-cell action in celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Paradoxical coexpression of proinflammatory and down-regulatory cytokines in intestinal T cells in childhood celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Costimulation of transduced T lymphocytes via T cell receptor-CD3 complex and CD28 leads to increased transcription of integrated retrovirus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Generation of regulatory gut-homing human T lymphocytes using ex vivo interleukin 10 gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302041

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302041

1 reference

6 August 2017

1 reference